Darusentan

From Citizendium
Revision as of 16:00, 4 August 2024 by Suggestion Bot (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Darusentan.png
darusentan
IUPAC name: (2S)-2-(4,6-dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic

acid

Synonyms:
Formula: C22H22N2O6

 Uses: hypertension

 Properties:

 Hazards: see side effects & drug interactions

Mass (g/mol): CAS #:
410.41988 171714-84-4


In medicine, darusentan is a medication for treating hypertension that is a selective endothelin type A antagonist. It is a vasodilator.[1]

Drug toxicity

Fluid retention is the most common drug toxicity.[1]

References

  1. 1.0 1.1 Weber MA et al. (2009) A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet DOI:10.1016/S0140-6736(09)61500-2